Navigation Links
Haemonetics Expands Its Blood Management Leadership With Acquisition of Neoteric Technology Ltd
Date:4/21/2009

ref='http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=HAE'> HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

Neoteric Technology Ltd. is a Vancouver, British Columbia based company that provides healthcare solutions to over 150 hospitals in Europe and North American. To learn more about Neoteric, visit our website at http://www.neoterictech.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Haemonetics Announces Change to Board of Directors
2. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
3. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
4. Haemonetics to Present at J.P. Morgan Healthcare Conference
5. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
6. Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009
7. Haemonetics Sets Date for First Quarter Fiscal Year 2009 Earnings Release and Conference Call - August 1, 2008
8. Haemonetics Chairman and CEO Adopts 10b5-1 Stock Trading Plan
9. Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in Fiscal 2009
10. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
11. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Morning Show On 101.9fm THE MIX/WTMX ... Will Be Event Host and Emcee, GURNEE, Ill., Oct. 2 ... one local boy, Jake Robert Widman, of Gurnee, won,t be,blowing out the ... of pediatric cancer called neuroblastoma on May 27, 2005, when he was,just ...
... and treatment of low-back pain has prompted the American ... (ACP) to issue a new treatment guideline. The guideline ... conducted by investigators at the Oregon Evidence-Based Practice Center ... recommendations issued by a panel of experts convened by ...
... to sudden cardiac death , TUESDAY, Oct. 2 ... perindopril, along with a beta blocker, may help ... Marfan syndrome, research shows. , Marfan syndrome, which ... excessive bone elongation and joint flexibility, and eye ...
... Calif., Oct. 2 Angel Flight West (AFW),awarded The ... at,AFW,s 24th Anniversary Awards on Saturday, September 29. Dr. ... year. As an AFW,pilot, he flies people in need ... and from medical facilities. Dr. Irish, like,all AFW volunteer ...
... gamma imaging for both ... NEWPORT NEWS, Va., Oct. 2 Recently published ... Gamma Imaging,(BSGI) may be more specific than MRI ... compiled by Dr. Rachel Brem and,colleagues at The ...
... 2 Aflac today announced,that Jeffrey M. Herbert ... officer of the company,s U.S. insurance operation. Herbert ... for his departure from the,company. (Logo: ... Aflac president and chief,operating officer for Aflac U.S., ...
Cached Medicine News:Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 3Health News:New clinical guideline for low-back pain 2Health News:New clinical guideline for low-back pain 3Health News:Drug Combo Helps Fight Marfan Syndrome 2Health News:Angel Flight West Recognizes Colorado Pilots and Supporters at AFW 24th Anniversary Awards 2Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 2Health News:Study Determines Breast-Specific Gamma Imaging Has Higher Specificity Than MRI in Patients With Equivocal Mammograms 3Health News:Aflac Announces Resignation of U.S. Marketing Officer 2Health News:Aflac Announces Resignation of U.S. Marketing Officer 3
(Date:1/15/2014)... Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ... body composition, including reductions in body fat content ...
(Date:1/14/2014)... BEVERLY HILLS, Calif. , Jan. 14, 2014 ... , offers Los Angeles a premier ... Duality laser and a $99 treatment special. Dr. Brandeis, focus ... medical technology and offering expert medical advice to all patients. ... a dramatic increase in the presence of tattoo regret and ...
(Date:1/14/2014)... 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ... across disciplines and even across industries. ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... NUTLEY, N.J., Jan. 14 Following an ... of PEGASYS(R),(peginterferon alfa-2a) in combination with ribavirin ... C, in the United States and globally.,Despite ... "IDEAL" study that potentially,favored patients taking Peg-Intron(TM) ...
... - MAA submission based on data from largest Phase 3 study conducted ... overall survival advantage compared to conventional ... compared to 26.2% for ... conventional care regimens, BOULDER, Colo., Jan. 14 Pharmion ...
Cached Medicine Technology:Roche responds to announcement of 'IDEAL' hepatitis C trial results 2Roche responds to announcement of 'IDEAL' hepatitis C trial results 3Roche responds to announcement of 'IDEAL' hepatitis C trial results 4Roche responds to announcement of 'IDEAL' hepatitis C trial results 5Roche responds to announcement of 'IDEAL' hepatitis C trial results 6Roche responds to announcement of 'IDEAL' hepatitis C trial results 7Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 2Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 3Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 4Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 5Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 6Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: